Description
Peptide Sciences Tesamorelin + Ipamorelin 6 mg/2 mg is a combination peptide product containing tesamorelin and ipamorelin, two compounds studied for their effects on growth hormone signaling. The listed formulation indicates 6 mg of tesamorelin and 2 mg of ipamorelin per vial; verify the product label for exact composition and packaging details.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It has an established medical use for reducing excess abdominal fat in adults with HIV-associated lipodystrophy under specific prescribing conditions. Ipamorelin is a growth hormone secretagogue studied for its interaction with ghrelin receptors and its potential to stimulate growth hormone release. Its safety and effectiveness for bodybuilding or physique enhancement have not been established.
Combining these compounds is of interest in research involving growth hormone regulation and related metabolic pathways. However, the effects of this specific combination on muscle growth, fat loss, recovery, or body composition have not been established through adequate clinical trials in healthy bodybuilders.
Product Benefits and Research Areas
- Growth hormone signaling research: Studies involving pathways that regulate growth hormone secretion.
- GHRH pathway investigation: Tesamorelin is studied for its action on growth hormone-releasing hormone receptors.
- Ghrelin receptor research: Ipamorelin is investigated for its activity at growth hormone secretagogue receptors.
- Metabolic research: Relevant to scientific investigation of body composition and energy metabolism.
- Combination peptide research: May be examined in controlled laboratory research exploring distinct mechanisms of growth hormone regulation.
Important Safety Information
Tesamorelin and ipamorelin should not be treated as proven bodybuilding or fat-loss solutions. Tesamorelin can affect glucose regulation and may cause fluid retention, joint discomfort, or injection-site reactions; it also requires careful consideration in people with certain medical conditions. The safety profile of ipamorelin and this combination is not sufficiently established for unsupervised use. This product should not be used without qualified medical oversight, and it is not a substitute for approved medical treatment.
Peptide Sciences product details and the stated vial strength should be verified against the manufacturer’s label. Research-oriented descriptions do not establish that a product is approved for human use.
Reviews
There are no reviews yet.